IP Library Granted Patent US 12673076
Granted Patent B2
US 12673076 · App. 15/034,500 · Granted Jul 7, 2026

Lactobactilus plantarum 2830 (ECGC 13110402) for use in treatments

Inventor: Stephen Patrick O'Hara (Heslington, GB)
Assignee: PROBIOTIX LIMITED
A61K35/747A23L33/10A23L33/135A23L33/21A61K38/43A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12673076
App. No.
15/034,500
Granted
Jul 7, 2026
Kind
B2
Abstract

The present invention relates to one or more strains of Lactobacilli and a cholesterol modifying agent (such as an oligosaccharide) for use in modifying the absorption of cholesterol in an individual or the treatment of heart disease, diabetes or obesity.

Claims (14)

1 . A composition comprising a strain of Lactobacilli having an elevated bile salt hydrolase activity and a galactooligosaccharide; wherein the strain is Lactobacillus plantarum 2830 (ECGC 13110402),

wherein the galactooligosaccharide is produced by the strain by reverse β-galactosidase reaction, and wherein

the composition further comprises an excipient and/or carrier compound;

the composition is in the form of a food stuff or a food additive;

the Lactobacillus plantarum 2830 is freeze-dried;

the composition further comprises at least one selected from: vitamins, minerals, phytochemicals and/or antioxidants; or

a combination thereof.

2 . The composition of claim 1 for modifying the absorption of cholesterol in an individual.

3 . The composition of claim 1 for treatment of high cholesterol, heart disease, diabetes or obesity.

4 . The composition of claim 1 , wherein the galactooligosaccharide comprises a selective growth medium for the strain of Lactobacilli.

5 . The composition of claim 1 , wherein the composition is encapsulated.

6 . The composition of claim 1 , in the form of a foodstuff and/or for use as a dietary supplement.

7 . The composition of claim 1 , further comprising a prebiotic.

8 . A method of producing a composition, the method comprising: mixing a composition according to claim 1 with a cholesterol modifying agent in a biologically effective amount.